Microfluidic Co-Encapsulation for Ligand-Induced Cell Expression Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current single-cell RNA sequencing techniques focus on individual cells and do not allow for the co-encapsulation and analysis of multiple cell types within the same microfluidic compartment, limiting the study of cell-cell interactions and the screening of drug candidates like monoclonal antibodies.
Innovation Solution
A method involving microfluidic compartments that co-encapsulate a first cell and a second cell or cell-free expression system expressing a ligand, along with barcode oligonucleotides, enabling the analysis of gene expression changes in response to the ligand, allowing for the identification of specific antibodies or ligands affecting cell behavior.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If single-cell RNA sequencing techniques are used to focus on individual cells, then measurement precision of single cell expression is improved, but the ability to analyze cell-cell interactions and co-encapsulation of multiple cell types is lost
Solution Approach 1:
The invention merges multiple cell types (e.g., plasma cells and cancer cells) into the same microfluidic compartment, allowing simultaneous analysis of cell-cell interactions while maintaining single-cell resolution through barcoding. This combining approach enables both individual cell expression profiling and interaction studies.
Solution Approach 2:
The invention introduces barcoded oligonucleotides as intermediaries that physically link multiple cells within a compartment to a common identifier. This mediator enables the association of expression data from different cell types with their interaction context, resolving the contradiction between individual cell precision and interaction analysis.
2Productivity
If conventional single-cell sequencing methods are used, then processing speed for individual cells is maintained, but throughput for screening millions of antibodies is limited
Solution Approach 1:
The invention combines multiple cells (plasma cells and cancer cells) into single compartments, enabling parallel processing of many antibody-cancer cell pairs simultaneously. This merging strategy increases screening throughput by analyzing multiple interactions in each compartment while maintaining manageable processing complexity.
Solution Approach 2:
The microfluidic compartment system serves multiple functions: it encapsulates cells, enables ligand secretion and interaction, performs barcoded labeling, and facilitates high-throughput screening. This multi-functionality allows the same system to handle both the biological interaction and the high-throughput screening requirement.
3Adaptability or versatility
If multiple cells are co-encapsulated in the same compartment, then cell-cell interaction analysis is enabled, but measurement precision of individual cell expression is reduced
Solution Approach 1:
The invention uses barcoded oligonucleotides as intermediaries that physically associate with mRNA from each cell type within the compartment. These barcodes serve as unique identifiers that maintain measurement precision for individual cell expression even when multiple cells are co-encapsulated, allowing distinction between plasma cell and cancer cell transcripts.
Solution Approach 2:
The invention applies different barcodes to different cell types or compartments, creating local quality differences that enable distinction between cells. This localized barcoding strategy maintains individual cell measurement precision while allowing co-encapsulation of multiple cell types for interaction analysis.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables high-throughput screening of millions of antibodies for hundreds or thousands of effects on cell expression patterns, facilitating the discovery of therapeutic antibodies by co-encapsulating plasma cells and cancer cells with barcoded primers, allowing for the identification of desired functional effects on gene expression.
Implementation Method 1
all cellular mRNAs hybridize with the barcoded polyT primers, thus ensuring a physical linkage with the barcode
Data Source
AI summary
The present invention relates to the field of microfluidics and in particular to analysing the gene expression of a cell in response to a ligand expressed in the same microfluidic compartment. By barcoding the transcriptome of the cell and of the expression system generating the ligand, the effect of the ligand on the cell expression can be discerned. The invention provides microfluidic compartments and methods for this purpose.